Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.

Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- Check7 days agoChange DetectedThe clinical trial record for AFPᶜ³³²T in advanced hepatocellular carcinoma is displayed with study details, eligibility criteria, locations, outcome measures, and posted results. It also includes record dates and study documents.SummaryDifference62%

- Check14 days agoChange DetectedThe displayed ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedAn NIH website-transition notice was added above the 403 error page, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check42 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content with a generic error screen.SummaryDifference19%

- Check63 days agoChange DetectedThe page now shows revision v3.7.0, replacing the previous v3.6.6, indicating a platform version update. This update does not modify the study content, eligibility criteria, or results data on the page.SummaryDifference0.0%

Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.